Brief: Seelos Therapeutics Retains Canaccord Genuity In Connection With Review Of Potential Partnerships And Collaborations
17/10/2023 13:11
Oct 17 (Reuters) - Seelos Therapeutics Inc SEEL.O :
* SEELOS THERAPEUTICS INC-RETAINS CANACCORD GENUITY IN
CONNECTION
WITH REVIEW OF POTENTIAL PARTNERSHIPS AND COLLABORATIONS
Source text for Eikon: ID:nPn5fQjrJa
Further company coverage: SEEL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Seelos Therapeutics
See all newsBrief: Seelos Therapeutics Commences Chapter 11 Proceedings- Court Filing
Brief: Seelos Therapeutics Announces Notice Of Delisting From Nasdaq And Transfer Of Listing To Over-The-Counter Market
Brief: Seelos Announces Postponement Of Its Annual Meeting Of Stockholders
Brief: Seelos Therapeutics Announces 1-For-16 Reverse Stock Split
U.S. STOCKS ON THE MOVE-Copper miners, Visa, Bluebird bio